U.S. market Closed. Opens in 1 day 4 hours 16 minutes

CBIO | Catalyst Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue794.00K7.34M20.95MN/A6.00K1.02M399.00K1.75M275.00K3.63M57.86M97.64M85.71M25.06M20.09M11.58M27.54M1.18M3.74M2.46M2.29M1.70M
Cost of Revenue798.00K7.38M9.16M43.86M21.47M12.85M10.55M5.96M5.27M6.56MN/AN/AN/A691.00K749.00K715.42K457.25K480.93K198.45K743.00K244.00KN/A
Gross Profit-4.00K-42.00K11.79M-43.86M-21.47M-11.83M-10.16M-4.21M-4.99M-2.93M57.86M97.64M85.71M24.37M19.34M10.86M27.08M698.98K3.54M1.72M2.04M1.70M
Operating Expenses30.40M87.85M69.16M57.28M33.83M22.84M20.82M15.55M29.67M50.84M62.28M107.38M72.60M64.70M47.48M42.63M27.48M30.64M27.93M21.78M23.05M10.45M
Selling, General & Admin17.37M18.96M16.18M13.42M12.35M9.99M9.26M9.59M10.17M12.01M13.19M12.17M8.05M8.17M6.50M8.01M5.70M6.39M5.16M3.60M4.13M2.30M
Research & Development13.04M68.89M52.98M43.86M21.47M12.85M11.55M5.96M19.50M38.84M49.09M95.22M64.55M40.18M40.98M34.62M21.79M24.25M22.77M18.18M16.24M8.15M
Other Operating ExpensesN/A-78.00K568.00K-46.00K1.65M261.00K86.00KN/A318.00K518.00K1.04MN/AN/A51.28M32.01M27.33B16.77BN/AN/AN/AN/AN/A
Operating Income-8.61M-87.89M-57.37M-57.28M-33.82M-21.82M-20.42M-13.80M-29.71M-47.22M-8.14M-9.74M13.12M-40.33M-28.14M-31.77M-403.69K-29.94M-24.39M-20.06M-21.00M-8.75M
Other Expenses / Income717.00K-39.00K1.13M2.10M3.77M261.00K3.47M-960.00K575.00K518.00K1.04M1.22M1.31M833.00K2.48M3.70B-832.48MN/A-4.20KN/AN/AN/A
Before Tax Income-7.89M-87.93M-56.24M-55.18M-30.05M-21.56M-16.95M-14.76M-29.14M-46.70M-7.10M-8.53M14.43M-39.49M-25.66M-28.07B-1.24BN/A-24.40MN/AN/AN/A
Income Tax Expenses348.00K-39.00K-699.00K-2.29M3.77M-173.00K3.08M518.00K3.48M7.00K-101.00K-2.48M3.53M-88.00K-4.28M-3.70M-2.50M-949.39K-368.04K19.39M21.07M7.30M
Net Income-8.24M-87.89M-55.54M-52.89M-30.05M-21.56M-16.95M-14.76M-32.62M-46.70M-7.00M-8.53M10.90M-39.40M-25.66M-28.07M2.10M-28.99M-24.03M-19.39M-21.07M-7.30M
Interest Expenses717.00KN/AN/AN/AN/AN/AN/A1.48M23.00K53.00K86.00K132.00K153.00K217.00K251.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding31.55M30.64M19.18M12.00M11.21M3.42M778.78K295.27K321.72K320.38K318.82K301.31K271.84K244.16K234.90K187.82K129.48K2.50K2.09K1.04K2.60K2.60K
Diluted Shares Outstanding31.55M30.64M19.18M12.00M11.21M3.42M778.78K295.27K321.72K320.38K318.82K301.31K287.15K244.16K234.90K187.82K129.48K2.50K2.09K1.04K2.60K2.60K
EBITDA-52.15M-87.60M-57.37M-57.28M-33.82M-21.82M-16.95M-12.81M-28.46M-47.22M-702.00K-9.74M13.12M-40.33M-28.14M-30.86M417.23K-29.14M-23.62M-20.06M-21.00M-8.75M
EBITDA Margin-6,568.39%-1,193.84%-273.87%0.00%-563,700.00%-2,143.61%-4,246.87%-732.23%-10,349.09%-1,301.07%-1.21%-9.98%15.30%-160.90%-140.12%-266.63%1.52%-2,469.47%-631.90%-816.27%-918.77%-513.86%
EBIT-7.18M-87.93M-56.24M-55.18M-26.29M-21.73M-13.86M-12.77M-29.12M-46.65M-7.01M-10.88M14.58M-39.27M-29.69M-31.77M-403.69K-29.94M-24.39MN/AN/AN/A
EBIT Margin-903.90%-1,198.32%-268.48%0.00%-438,133.33%-2,134.97%-3,473.93%-729.49%-10,587.64%-1,285.34%-12.12%-11.14%17.01%-156.71%-147.84%-274.46%-1.47%-2,537.54%-652.51%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙